Title : The targeted histone deacetylase inhibitor tefinostat (CHR-2845) shows selective in vitro efficacy in monocytoid-lineage leukaemias - Zabkiewicz_2016_Oncotarget_7_16650 |
Author(s) : Zabkiewicz J , Gilmour M , Hills R , Vyas P , Bone E , Davidson A , Burnett A , Knapper S |
Ref : Oncotarget , 7 :16650 , 2016 |
Abstract : Zabkiewicz_2016_Oncotarget_7_16650 |
ESTHER : Zabkiewicz_2016_Oncotarget_7_16650 |
PubMedSearch : Zabkiewicz_2016_Oncotarget_7_16650 |
PubMedID: 26934551 |
Zabkiewicz J, Gilmour M, Hills R, Vyas P, Bone E, Davidson A, Burnett A, Knapper S (2016)
The targeted histone deacetylase inhibitor tefinostat (CHR-2845) shows selective in vitro efficacy in monocytoid-lineage leukaemias
Oncotarget
7 :16650
Zabkiewicz J, Gilmour M, Hills R, Vyas P, Bone E, Davidson A, Burnett A, Knapper S (2016)
Oncotarget
7 :16650